Splet13. dec. 2016 · Interestingly, TP53 mutations were found to be significantly more common in DLBCL with MYC translocations ( r = 0.446, P = 0.034). While no gene mutation was found to be more prevalent in patients with DLBCL with bone marrow involvement, MYD88 mutations were more common in primary DLBCL of the CNS or testis. Splet13. dec. 2016 · Schematic overview of the mutational pattern of CD58 and TP53 genes in DLBCL. Distinct gene mutations in 165 cases of DLBCL, NOS were described. A. …
Cancers Free Full-Text Influence of TP53 Mutation on Survival …
SpletThe TP53 gene is involved in maintaining genomic stability in response to DNA damage by activating DNA repair programs and by triggering cell cycle arrest. The loss of TP53 is associated with lymphomagenesis and resistance to chemotherapy. 6 TP53 mutations are present in 10% of DLBCL patients and confer a poor prognosis in patients treated with ... Splet09. nov. 2024 · Refractory/relapsed diffuse large B-cell lymphoma (DLBCL) is associated with poor outcome. The clinical behavior and genetic landscape of DLBCL is heterogeneous and still not fully understood. TP53 mutations in DLBCL have been identified as markers of poor prognosis and are often associated with therapeutic resistance. Chimeric antigen … litter aluminum cans 100 years
非霍奇金淋巴瘤 ‖ 弥漫性大B细胞淋巴瘤的分子分型研究进展 - 知乎
Splet29. mar. 2024 · TP53 mutations also stratified patients with germinal center B cell-like DLBCL, but not nongerminal center B cell-like DLBCL, into molecularly distinct subsets with different survivals. This study shows the prognostic importance of mutations in the TP53 DNA-binding domains in patients with DLBCL. Splet03. maj 2024 · TP53 exon 8 G/C-to-A/T mutation was detected in R/R DLBCL. Total DNA were extracted from FFPE DLBCL tissues and TP53 exon 8 was amplified by 3D-PCR and sequenced by Sanger sequencing. Sequences were aligned and analyzed with the Clustal and Genedoc software. * indicates the number in the middle of the two numbers before … Splet28. okt. 2024 · TP53 mutations have been observed in diffuse large B-cell lymphoma (DLBCL), with a mean frequency of ~20%. Studies on TP53 mutations as prognostic … litteraly yes not figurmentaly